Sunnyvale, CA, United States of America

Simon C Shorter

This inventor holds 1 USPTO granted patent. Top assignee: Isis Innovation Limited. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon C Shorter. Retrieved from https://idiyas.com/inventor/simon-c-shorter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon C Shorter: Innovator in Monoclonal Antibodies

Introduction

Simon C Shorter is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical research and therapeutic applications.

Latest Patents

Simon C Shorter holds a patent for the "Cytotrophoblast antigen and monoclonal antibodies which specifically." This innovation represents a step forward in the understanding and treatment of various medical conditions.

Career Highlights

Simon is associated with Isis Innovation Limited, where he applies his expertise in biotechnology. His role at the company allows him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Some of his coworkers include Christopher W Redman and Phyllis M Starkey. Their collective efforts enhance the research environment and foster innovation within the company.

Conclusion

Simon C Shorter is a distinguished inventor whose work in monoclonal antibodies has the potential to impact medical science significantly. His contributions continue to pave the way for future advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…